Novartis gene/cell therapy, cancer news

Novartis is dissolving its Cell and Gene Therapies Unit and re-integrating the unit’s activities into its larger organization. The stand-alone unit was created in 2014.

In May, Novartis said it would split its pharmaceuticals division into two new units, Novartis Pharmaceuticals and Novartis Oncology, which together form Novartis’ new Innovative Medicines division. Novartis Oncology includes cancer programs and cell and gene therapies. ...